- Report
- February 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- September 2026
- 180 Pages
Global
From €3196EUR$3,545USD£2,746GBP
€3551EUR$3,939USD£3,051GBP
- Report
- September 2026
- 188 Pages
Global
From €5273EUR$5,850USD£4,531GBP
- Report
- February 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- October 2025
- 160 Pages
Global
From €2849EUR$3,160USD£2,447GBP
€3561EUR$3,950USD£3,059GBP
- Report
- August 2025
- 238 Pages
Global
From €4417EUR$4,900USD£3,795GBP
- Report
- July 2025
- 160 Pages
United States
From €4462EUR$4,950USD£3,834GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4462EUR$4,950USD£3,834GBP
- Report
- November 2025
- 132 Pages
Global
From €856EUR$950USD£736GBP
- Report
- April 2024
- 132 Pages
Global
From €856EUR$950USD£736GBP

Peripheral Arterial Disease (PAD) is a cardiovascular condition characterized by a narrowing of the arteries that supply blood to the limbs. It is caused by a buildup of plaque in the arteries, which can lead to a decrease in blood flow and oxygen to the legs and feet. Symptoms of PAD include pain in the legs and feet, numbness, and a decrease in the ability to walk. PAD is a major cause of disability and can lead to serious complications such as stroke, heart attack, and amputation. Treatment for PAD includes lifestyle changes, medications, and surgery.
The PAD market is a subset of the larger cardiology market, which includes treatments for a variety of cardiovascular conditions. Companies in the PAD market include Abbott, Boston Scientific, Medtronic, and Johnson & Johnson. These companies offer a range of products and services, including diagnostic tests, medical devices, and pharmaceuticals. Show Less Read more